<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Muiru AN</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>National Institute on Alcohol Abuse and Alcoholism</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>National Institute of Nursing Research</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>National Institute on Deafness and Other Communication Disorders</funding><funding>Ontario Ministry of Health and Long-Term Care</funding><funding>National Institutes of Health</funding><funding>Health Resources and Services Administration</funding><funding>National Human Genome Research Institute</funding><funding>Canadian Institutes of Health Research</funding><funding>National Institute on Aging</funding><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Agency for Healthcare Research and Quality</funding><funding>Centers for Disease Control and Prevention</funding><funding>NIDDK NIH HHS</funding><funding>National Cancer Institute</funding><funding>National Institute of Mental Health</funding><funding>National Institute of Dental and Craniofacial Research</funding><funding>National Institute on Drug Abuse</funding><pagination>461-468</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10169400</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>76(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The impact of adopting a race-free estimated glomerular filtration rate (eGFR) creatinine (eGFRcr) equation on racial differences in chronic kidney disease (CKD) progression among people with human immunodeficiency virus (PWH) is unknown.&lt;h4>Methods&lt;/h4>We defined eGFR stages using the original race-adjusted Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFRcr equation and the new race-free CKD-EPI eGFRcr equation. We then estimated 5-year probabilities of transitioning from baseline kidney function to more advanced eGFR stages and examined the association of race (black vs white) with rates of CKD progression using Markov models.&lt;h4>Results&lt;/h4>With the race-adjusted eGFRcr equation, black participants (n = 31 298) had a lower risk of progressing from eGFR</pubmed_abstract><journal>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</journal><pubmed_title>Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study.</pubmed_title><pmcid>PMC10169400</pmcid><funding_grant_id>K23 DK119562</funding_grant_id><funding_grant_id>K23EY013707</funding_grant_id><funding_grant_id>P30MH62246</funding_grant_id><funding_grant_id>U01HL146208</funding_grant_id><funding_grant_id>R24AI067039</funding_grant_id><funding_grant_id>U01AI038855</funding_grant_id><funding_grant_id>U10EY008067</funding_grant_id><funding_grant_id>U01HL146333</funding_grant_id><funding_grant_id>U01AI069918</funding_grant_id><funding_grant_id>U01AI038858</funding_grant_id><funding_grant_id>CDC-200-2006-18797</funding_grant_id><funding_grant_id>K24AI118591</funding_grant_id><funding_grant_id>F31DA037788</funding_grant_id><funding_grant_id>U01AI069434</funding_grant_id><funding_grant_id>UL1RR024131</funding_grant_id><funding_grant_id>TGF-96118</funding_grant_id><funding_grant_id>R01AA016893</funding_grant_id><funding_grant_id>CBR-94036</funding_grant_id><funding_grant_id>HCP-97105</funding_grant_id><funding_grant_id>U54GM133807</funding_grant_id><funding_grant_id>P30AI036219</funding_grant_id><funding_grant_id>U10EY008057</funding_grant_id><funding_grant_id>N02CP055504</funding_grant_id><funding_grant_id>U01AI068636</funding_grant_id><funding_grant_id>U01AA020790</funding_grant_id><funding_grant_id>G12MD007583</funding_grant_id><funding_grant_id>K24DA035684</funding_grant_id><funding_grant_id>U01AI068634</funding_grant_id><funding_grant_id>R01DA012568</funding_grant_id><funding_grant_id>KL2TR000421</funding_grant_id><funding_grant_id>F31AI124794</funding_grant_id><funding_grant_id>U01DA03629</funding_grant_id><funding_grant_id>U10EY008052</funding_grant_id><funding_grant_id>CDC-200-2015-63931</funding_grant_id><funding_grant_id>K24DA000432</funding_grant_id><funding_grant_id>R01DA026770</funding_grant_id><funding_grant_id>P30AI050409</funding_grant_id><funding_grant_id>U24AA020794</funding_grant_id><funding_grant_id>P30AI050410</funding_grant_id><funding_grant_id>P30AI110527</funding_grant_id><funding_grant_id>U01DA036935</funding_grant_id><funding_grant_id>N01CP01004</funding_grant_id><funding_grant_id>U01HL146194</funding_grant_id><funding_grant_id>P30AI027757</funding_grant_id><funding_grant_id>U01HL146193</funding_grant_id><funding_grant_id>U01HL146192</funding_grant_id><funding_grant_id>R01 AG053100</funding_grant_id><funding_grant_id>U01AI069432</funding_grant_id><funding_grant_id>90051652</funding_grant_id><funding_grant_id>UL1TR000004</funding_grant_id><funding_grant_id>UL1TR000083</funding_grant_id><funding_grant_id>CBR-86906</funding_grant_id><funding_grant_id>K01AI131895</funding_grant_id><funding_grant_id>K01AI093197</funding_grant_id><funding_grant_id>R01DA011602</funding_grant_id><funding_grant_id>N02CP91027</funding_grant_id><funding_grant_id>P30AI027763</funding_grant_id><funding_grant_id>90047713</funding_grant_id><funding_grant_id>Z01CP010176</funding_grant_id><funding_grant_id>U01HL146205</funding_grant_id><funding_grant_id>U01HL146204</funding_grant_id><funding_grant_id>U01HL146203</funding_grant_id><funding_grant_id>U01HL146202</funding_grant_id><funding_grant_id>U01HL146201</funding_grant_id><funding_grant_id>U01HL146245</funding_grant_id><funding_grant_id>Z01CP010214</funding_grant_id><funding_grant_id>U01HL146242</funding_grant_id><funding_grant_id>U01HL146241</funding_grant_id><funding_grant_id>P30AI094189</funding_grant_id><funding_grant_id>U01HL146240</funding_grant_id><funding_grant_id>U01AA013566</funding_grant_id><funding_grant_id>K24AI065298</funding_grant_id><funding_grant_id>P30AI027767</funding_grant_id><pubmed_authors>Klein MB</pubmed_authors><pubmed_authors>Shlipak MG</pubmed_authors><pubmed_authors>Mayor AM</pubmed_authors><pubmed_authors>Koethe JR</pubmed_authors><pubmed_authors>Napravnik S</pubmed_authors><pubmed_authors>Crane HM</pubmed_authors><pubmed_authors>Madden E</pubmed_authors><pubmed_authors>John Gill M</pubmed_authors><pubmed_authors>Scherzer R</pubmed_authors><pubmed_authors>Estrella MM</pubmed_authors><pubmed_authors>Marconi VC</pubmed_authors><pubmed_authors>Muiru AN</pubmed_authors><pubmed_authors>Lucas GM</pubmed_authors><pubmed_authors>Althoff KN</pubmed_authors><pubmed_authors>Abraham AG</pubmed_authors><pubmed_authors>Horberg MA</pubmed_authors><pubmed_authors>Silverberg MJ</pubmed_authors><pubmed_authors>Moore RD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study.</name><description>&lt;h4>Background&lt;/h4>The impact of adopting a race-free estimated glomerular filtration rate (eGFR) creatinine (eGFRcr) equation on racial differences in chronic kidney disease (CKD) progression among people with human immunodeficiency virus (PWH) is unknown.&lt;h4>Methods&lt;/h4>We defined eGFR stages using the original race-adjusted Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFRcr equation and the new race-free CKD-EPI eGFRcr equation. We then estimated 5-year probabilities of transitioning from baseline kidney function to more advanced eGFR stages and examined the association of race (black vs white) with rates of CKD progression using Markov models.&lt;h4>Results&lt;/h4>With the race-adjusted eGFRcr equation, black participants (n = 31 298) had a lower risk of progressing from eGFR</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-26T14:27:42.387Z</modification><creation>2025-04-06T14:33:21.131Z</creation></dates><accession>S-EPMC10169400</accession><cross_references><pubmed>36069064</pubmed><doi>10.1093/cid/ciac731</doi></cross_references></HashMap>